3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Colorectal Neoplasms
2
Prostatic Neoplasms
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Adenocarcinoma Of Esophagus
1
Interventions
Gemcitabine
15
Cisplatin
15
pembrolizumab
9
Oxaliplatin
7
durvalumab
5
Leucovorin
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
Platinum
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
Trastuzumab
3
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
Biopsy
3
zanidatamab
2
Paclitaxel
2
Nivolumab
2
Folfox protocol
2
Docetaxel
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
pertuzumab
1
peposertib
1
lenvatinib
1
guadecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Gene Expression Profiling
×
1 year
×
Clear all
No trials found.